Brown Brothers Harriman & Co. Takes $27.29 Million Position in Certara, Inc. (NASDAQ:CERT)

Brown Brothers Harriman & Co. acquired a new position in shares of Certara, Inc. (NASDAQ:CERT) in the 3rd quarter, Holdings Channel reports. The fund acquired 2,330,615 shares of the company’s stock, valued at approximately $27,292,000.

Several other institutional investors also recently modified their holdings of CERT. Sei Investments Co. grew its stake in Certara by 39.5% in the 2nd quarter. Sei Investments Co. now owns 997,871 shares of the company’s stock worth $13,821,000 after buying an additional 282,357 shares in the last quarter. Silvercrest Asset Management Group LLC lifted its holdings in shares of Certara by 27.3% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 516,300 shares of the company’s stock worth $9,231,000 after acquiring an additional 110,636 shares during the last quarter. Daventry Group LP grew its position in Certara by 153.0% in the second quarter. Daventry Group LP now owns 1,308,572 shares of the company’s stock worth $18,124,000 after acquiring an additional 791,405 shares in the last quarter. Massachusetts Financial Services Co. MA increased its stake in Certara by 40.7% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,901,898 shares of the company’s stock valued at $45,691,000 after acquiring an additional 1,128,006 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC raised its position in Certara by 8.4% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 810,206 shares of the company’s stock valued at $11,221,000 after purchasing an additional 62,912 shares in the last quarter. 73.96% of the stock is currently owned by institutional investors.

Certara Stock Up 6.0 %

Shares of CERT stock opened at $10.36 on Monday. The business has a 50-day moving average of $10.79 and a 200 day moving average of $13.17. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.86 and a current ratio of 2.86. Certara, Inc. has a 1-year low of $9.41 and a 1-year high of $19.87.

Certara (NASDAQ:CERT) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.02. Certara had a positive return on equity of 3.43% and a negative net margin of 8.34%. The firm had revenue of $94.80 million during the quarter, compared to the consensus estimate of $95.51 million. During the same quarter in the previous year, the company posted $0.06 earnings per share. The business’s revenue was up 10.7% on a year-over-year basis. On average, equities analysts anticipate that Certara, Inc. will post 0.28 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. Barclays cut their price objective on Certara from $14.00 to $12.00 and set an “equal weight” rating for the company in a report on Thursday, November 7th. UBS Group raised Certara from a “neutral” rating to a “buy” rating and set a $16.00 target price for the company in a research note on Friday, September 27th. Finally, Robert W. Baird decreased their price target on shares of Certara from $18.00 to $13.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 5th. Six investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $15.92.

Insider Buying and Selling at Certara

In other news, insider Patrick F. Smith sold 5,409 shares of the business’s stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $11.03, for a total transaction of $59,661.27. Following the transaction, the insider now directly owns 50,091 shares of the company’s stock, valued at approximately $552,503.73. The trade was a 9.75 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Leif E. Pedersen sold 51,224 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $11.29, for a total value of $578,318.96. Following the transaction, the insider now owns 99,704 shares of the company’s stock, valued at approximately $1,125,658.16. This represents a 33.94 % decrease in their position. The disclosure for this sale can be found here. 2.39% of the stock is currently owned by corporate insiders.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.